Brief: Astrazeneca Pharma India Sept-Quarter PAT Rises
11/11/2022 10:44
Nov 11 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA SEPT-QUARTER PAT 325.6 MILLION RUPEES VERSUS
119.5
MILLION RUPEES
* ASTRAZENECA PHARMA INDIA SEPT-QUARTER REVENUE FROM OPERATIONS 2.36 BILLION
RUPEES VERSUS 1.98 BILLION RUPEES
Source text for Eikon: ID:nBSE1qVT47
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan